Table 1 TGGA patient cohort characteristics
From: Aberrant miRNAs expressed in HER-2 negative breast cancers patient
Demographics | TNBC (n = 112) | DPBC (n = 358) |
|---|---|---|
Sex | ||
Males | 0 | 3 |
Females | 112 | 355 |
Age | ||
Median, Range | 54, 29–90 | 58, 28–90 |
Median, Range ♂ | – | 68, 44–84 |
Median, Range ♀ | 54, 29–90 | 58, 28–90 |
Menopausal status | ||
Pre-menopausal | 30 | 89 |
Peri-menopausal | 5 | 16 |
Post-menopausal | 68 | 225 |
Unknown, N/A | 9 | 28 |
TNM | ||
T1 | 27 | 110 |
T2 | 70 | 189 |
T3 | 11 | 48 |
T4 | 4 | 10 |
Tx | – | 1 |
N0 | 72 | 168 |
N1 | 25 | 121 |
N2 | 11 | 39 |
N3 | 4 | 25 |
Nx | – | 5 |
M0 | 95 | 308 |
Mx | 17 | 50 |
Turmor grade | ||
I | 20 | 72 |
II | 70 | 195 |
III | 18 | 82 |
IV | 1 | 3 |
X / unknown | 3 | 6 |